ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,106.59
-0.61%
US Tech 100
21,388.60
-0.89%
다우존스 지수
44,220.58
-0.91%
Bitcoin
97,207.95
0.60%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Zenas BioPharma Inc (ZBIO) 시세

Zenas BioPharma Inc

Zenas BioPharma Inc (ZBIO)

NASDAQ
7.05
0.62
( 9.64% )
업데이트: 00:05:57
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
7.05
매수가
7.01
매도가
7.11
거래량
16,892
6.80 일간 변동폭 7.10
5.83 52주 범위 26.11
market_cap
294.627M
전일 종가
6.43
개장가
6.80
최근 거래 시간
2
@
7.11
마지막 거래 시간
00:05:43
재정 규모
US$ 116,615
VWAP
6.9036
평균 볼륨(3m)
318,108
발행 주식
41,791,037
배당수익률
-
주가수익률
-8.06
주당순이익(EPS)
-0.89
매출
50M
순이익
-37.12M

Zenas BioPharma Inc 정보

Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. We leverage our experienced executive management team and our established networks throughout t... Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. We leverage our experienced executive management team and our established networks throughout the biopharmaceutical industry to identify, acquire and develop product candidates that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Our lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We are developing obexelimab for patients in several autoimmune diseases. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Wilmington, Delaware, USA
설립됨
-
Zenas BioPharma Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ZBIO. The last closing price for Zenas BioPharma was US$6.43. Over the last year, Zenas BioPharma shares have traded in a share price range of US$ 5.83 to US$ 26.11.

Zenas BioPharma currently has 41,791,037 shares in issue. The market capitalisation of Zenas BioPharma is US$268.72 million. Zenas BioPharma has a price to earnings ratio (PE ratio) of -8.06.

ZBIO 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
12 2월 2025
ZBIO (9.64%)

Form 8-K - Current report
Edgar (US Regulatory)
05 2월 2025
ZBIO (9.64%)

Form 8-K - Current report
Edgar (US Regulatory)
12 11월 2024
ZBIO (9.64%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.16-2.219140083227.217.416.371349836.73551711CS
4-1.33-15.87112171848.388.55.832067227.31998983CS
12-4.7-4011.7511.875.833181089.11811855CS
26-2.9704-29.643527204510.020426.115.8322525612.27304989CS
52-2.9704-29.643527204510.020426.115.8311172712.27304989CS
156-2.9704-29.643527204510.020426.115.833724212.27304989CS
260-1.34-15.97139451738.3926.115.832590312.21882254CS

ZBIO - Frequently Asked Questions (FAQ)

What is the current Zenas BioPharma share price?
The current share price of Zenas BioPharma is US$ 7.05
How many Zenas BioPharma shares are in issue?
Zenas BioPharma has 41,791,037 shares in issue
What is the market cap of Zenas BioPharma?
The market capitalisation of Zenas BioPharma is USD 268.72M
What is the 1 year trading range for Zenas BioPharma share price?
Zenas BioPharma has traded in the range of US$ 5.83 to US$ 26.11 during the past year
What is the PE ratio of Zenas BioPharma?
The price to earnings ratio of Zenas BioPharma is -8.06
What is the cash to sales ratio of Zenas BioPharma?
The cash to sales ratio of Zenas BioPharma is 5.98
What is the reporting currency for Zenas BioPharma?
Zenas BioPharma reports financial results in USD
What is the latest annual turnover for Zenas BioPharma?
The latest annual turnover of Zenas BioPharma is USD 50M
What is the latest annual profit for Zenas BioPharma?
The latest annual profit of Zenas BioPharma is USD -37.12M
What is the registered address of Zenas BioPharma?
The registered address for Zenas BioPharma is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Zenas BioPharma operate in?
Zenas BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
XOSXos Inc
US$ 5.93
(89.46%)
19.63M
WOKWORK Medical Technology Group Ltd
US$ 4.4001
(76.71%)
62.36M
SHOTWSafety Shot Inc
US$ 0.37
(73.55%)
10.27k
MNDRMobile health Network Solutions
US$ 0.4807
(45.98%)
50.32M
RETOReTo Eco Solutions Inc
US$ 0.5375
(36.08%)
15.47M
MTLSMaterialise NV
US$ 6.43
(-30.26%)
496.07k
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 198.00
(-23.47%)
885.55k
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 41.9782
(-23.38%)
2.2M
TRUPTrupanion Inc
US$ 36.70
(-22.75%)
531.65k
INBSIntelligent Bio Solutions Inc
US$ 2.0897
(-20.84%)
360.16k
APTOAptose Biosciences Inc
US$ 0.1861
(24.15%)
119.16M
ADTXAditxt Inc
US$ 0.1059
(-17.65%)
72.55M
PLTRPalantir Technologies Inc
US$ 99.0749
(-11.59%)
70.51M
FGENFibroGen Inc
US$ 0.7089
(26.14%)
67.66M
WOKWORK Medical Technology Group Ltd
US$ 4.40
(76.71%)
62.38M

토론

전체 피드 보기
SkeBallLarry SkeBallLarry 44 초 전
" LOL " .. !! . a Gem .. !
green maschine green maschine 44 초 전
I jumped out pm. That was quite a surprise that it's still dropping.
CYCU
John Doe 2024 John Doe 2024 44 초 전
Keith Duffy should face another lawsuit from shareholders for misleading investors for over 4 years. We should go after his money for once.
XERI
dinogreeves dinogreeves 48 초 전
Around 2 PM it should come back up and close flat maybe. Keynote presentation
SMCI
georgie18 georgie18 52 초 전
XLHD...15,000 share buy at $1.91...🥳

georgie18

Member Level
Re: georgie18 post# 8

Wednesday, February 19, 2025 2:47:44 PM

Post#
9
of 13
XHLD...$1.95...Nice biuying here with some 10,000 share blocks...
XHLD
al44 al44 57 초 전
DOGE takes on the Social Security monster

By Monica Showalter


Seems the demand for supplicants on SSI disability benefits exceeded supply, so bureaucrats got busy, seeking out illegals to fill out the disability rolls -- for lifetime benefits.

Wit
DanM51 DanM51 1 분 전
I'm glad some of the lwlg shareholders pointed me to the s**tshow that is NB. It's so good for a laugh. I mean, a $500,000 cybersecutity "hack" loss (screams embezzlement?) AND a dilution filing. It's hilarious.....on well, I guess NB investors can switch their money over to the next greatest inves
LWLG
georgie18 georgie18 1 분 전
XLHD...15,000 share buy at $1.91...🥳

georgie18

Member Level
Re: georgie18 post# 8

Wednesday, February 19, 2025 2:47:44 PM

Post#
9
of 13
XHLD...$1.95...Nice biuying here with some 10,000 share blocks...
XHLD
georgie18 georgie18 1 분 전
XLHD...15,000 share buy at $1.91...🥳

georgie18

Member Level
Re: georgie18 post# 8

Wednesday, February 19, 2025 2:47:44 PM

Post#
9
of 13
XHLD...$1.95...Nice biuying here with some 10,000 share blocks...
XHLD
fung_derf fung_derf 1 분 전
Technical analysis is not luck.
SMCI
tw0122 tw0122 1 분 전
$13.08 Nice ..slapped $25 target by Citi
georgie18 georgie18 1 분 전
XLHD...15,000 share buy at $1.91...🥳

georgie18

Member Level
Re: georgie18 post# 8

Wednesday, February 19, 2025 2:47:44 PM

Post#
9
of 13
XHLD...$1.95...Nice biuying here with some 10,000 share blocks...
XHLD
GTF GTF 2 분 전
https://x.com/ABIntlGroup/status/1892584061920780588

Things are happening
ABQQ
TESLIN TESLIN 2 분 전
Blatant manipulation!!!!
CCL
Jaguarjacket Jaguarjacket 2 분 전
Wow, ADIA GOING BIG TIME!
ADIA
MackG MackG 2 분 전
I am not talking about IPIX mistakes. The focus on my recent posts is the substantial ownership interest IPIX has in BeaMed Technologies, LTD. Keep yapping about IPIX if you choose. That is obviously what you enjoy doing.
IPIX
JMCK6193 JMCK6193 2 분 전
Encrypted message 
(Try to stay up)
39-43 💪 $NXPL 
NXPL
RickNagra RickNagra 2 분 전
Wrong.  It will be Pulte's job to submit the necessary paperwork to get re-listed on the NYSE.
FNMA
jhdf51 jhdf51 2 분 전
Absolutely… I do believe $150 by year end.

JHD
COOP
train21 train21 2 분 전
$PSRU YEP LOAD UP THE CHEAPIES IF YOU CAN
XAVIER GOT A LOT OF IRONS IN THE FIRE
AND ALL WE NEED IS JUST ONE TO LIGHT THE FIREWORKS TO COPPER $$$$$$$$$
PSRU
vlispxpert vlispxpert 2 분 전
PSQH, next monster add at 2.80's..nibbling on way down
PSQH
Cynmark24 Cynmark24 3 분 전
I don't miss black ops
 Loved reading his stories, but with his lifetime of experiences he was not able to see thru the scam that pushed the price to 10 followed by the immediate collapse.
CYDY
JRoon71 JRoon71 3 분 전
Skipper, sort of what I was thinking. Doesn't make sense if they are planning a BB. But it's also *possible* that they just keep those two transactions independent of each other, mostly for bookkeeping purposes. Because share awards have to come from somewhere. So they either have to issue new share
AMRN
Jaguarjacket Jaguarjacket 3 분 전
Glad I loaded more this am! This is amazing news. Wow
ADIA
green maschine green maschine 3 분 전
R/S on Feb 26th
APTO

최근 히스토리

NASDAQ
ZBIO
Zenas BioPharma
LSE
TINF
Tinf Us (usd)
NASDAQ
OXLC
Oxford Lane Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지